+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Glucose Monitoring Global Market Report - Forecast to 2025

  • ID: 4774710
  • Report
  • Region: Global
  • IQ4I Research & Consultancy Pvt. Ltd
UP TO OFF
until Dec 31st 2019
1 of 4
The Glucose Monitoring Global Market is Expected to Grow at CAGR of Xx% Reach $12,897.0 Million by 2025.

FEATURED COMPANIES

  • A&T CORPORATION
  • BIO-RAD LABORATORIES
  • EKF DIAGNOSTICS
  • HUBDIC CO LTD
  • LIGHT TOUCH MEDICAL INC
  • PEPEX BIOMEDICAL
  • MORE

Glucose Monitoring consists of products that are essential for patients suffering from diabetes. With the projected rise in the aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products. Factors driving the Glucose Monitoring market are a global rise in the prevalence and incidence of diabetes, continuous technological advancement, increasing demand for less invasive products, and an increase in R&D investments that are driving the market growth. An increase in the obesity population due to lifestyle changes, an increase in urbanization, untapped markets like the Middle East, Africa shows that the glucose monitoring market has vast opportunities in the coming years. Frequent product recalls i.e. glucose testing strips due to manufacturing defects or supply of expired test strips and less product differentiation among the self blood glucose monitors are the factors that are restraining the market growth. The limited reimbursement facilities and alternative treatments that include cell-based assays, biomarkers identification, and artificial pancreas and high cost associated with Continuous Glucose Monitoring (CGM) are threats for the market growth.

Glucose Monitoring global market is classified based on products, sample type, end-users, and geography. The product segment is divided into three segments i.e., Invasive, Non-Invasive and lab-based glucose monitoring products. The Invasive glucose monitoring products segment accounted for the largest share in 2018 and is projected to grow at a low single-digit CAGR from 2018 to 2025 due to technological advancements, easy use, patient-friendly, etc. Invasive products are classified into Self glucose monitoring and continuous glucose products. The self glucose monitoring segment accounted for the largest share in 2018 due to the development of minimally invasive products. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2018 due to the development of no coding strips. The continuous glucose monitoring market includes sensors/receivers and transmitters. The continuous glucose market includes products sensors/receivers and transmitters. The continuous glucose segment is the fastest growing segment and is projected to grow at a strong double-digit CAGR from 2018 to 2025.

Based on sample type the market is segmented into blood, urine, and others. The blood segment accounted for the largest share in 2018 due to the accuracy of results. Other source based glucose monitoring segment is the fastest growing segment and is projected to grow exponentially from 2018 to 2025 due to increases R&D investment, many products are CE approved and expected launch very soon in the market.

Based on end users the market is segmented into hospitals, private clinics, home care, and ambulatory settings. Among end-users, home care segment accounted for the largest share in 2018 and is projected to grow at a low single-digit CAGR from 2018 to 2025 due to the availability of over the counter (OTC) self blood glucose monitor and ease in operating these monitors and thereby reducing the frequent visits to hospitals or clinics for checking glucose levels.

Based on geography the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy, and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Middle East & others and Rest of Latin America). North America accounts for the highest market share followed by Europe. The steep rise in the aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of the glucose monitoring market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for glucose monitoring products.

Major players in Glucose monitoring market include Abbott Laboratories (U.S.), Roche (Switzerland), LifeScan (U.S.), Dexcom (U.S.), Medtronic, Inc. (Ireland), Ascensia (Switzerland), Arkray (Japan), Sinocare (China), B. Braun Melsungen AG (Germany), Bio-Rad (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • Germany
    • Italy
    • France
    • Rest of EU
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of APAC
  • Rest of the World (RoW)
    • Brazil
    • Rest of Latin America
    • Middle-East (Middle East & Others)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • A&T CORPORATION
  • BIO-RAD LABORATORIES
  • EKF DIAGNOSTICS
  • HUBDIC CO LTD
  • LIGHT TOUCH MEDICAL INC
  • PEPEX BIOMEDICAL
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Breakdown and Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points from Secondary Sources
2.5.6 Key Data Points from Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 The Global Rise in The Prevalence and Incidence of Diabetes
3.3.1.2 Technological Advancements in Glucose Monitoring Devices
3.3.1.3 Increasing Demand for Less Invasive Devices or Point of Care
3.3.1.4 Increasing R & D Investments
3.3.2 Restraints and Threats
3.3.2.1 Availability of Alternative Treatment
3.3.2.2 High Cost Associated With the Products
3.3.2.3 Inadequate Reimbursement
3.3.2.4 Product Recalls
3.3.2.5 Strict Regulation of Glucose Monitoring Devices by Regulatory Organizations Like the Fda and Others.
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 India
3.4.5 Japan
3.5 Reimbursement Scenario
3.6 Patent Analysis
3.7 Technology Advancements
3.7.1 Artificial Intelligence and Radar Technology
3.7.2 Non-Invasive Continuous Glucose Monitoring Wearable
3.7.3 Tear Glucose Monitoring Technology
3.7.4 Saliva-Based Biosensors
3.7.5 Micro-needle Patch
3.7.6 Photothermal Detection of Glucose Levels
3.8 Product Launches and Approvals
3.9 Funding Scenario
3.10 Glucose Monitoring - Deals
3.11 Clinical Trial Data
3.12 Porter’s Five Force Analysis
3.12.1 Threat of New Entrants
3.12.2 Threat of Substitutes
3.12.3 Bargaining Power of Suppliers
3.12.4 Bargaining Power of Buyers
3.12.5 Rivalry Among Existing Competitors
3.13 Supply Chain Analysis
3.14 Market Share Analysis by Major Players
3.14.1 Glucose Monitoring Global Market Share Analysis
3.14.2 Self Blood Glucose Monitoring Global Market Share
3.14.3 Continuous Glucose Monitoring Global Market

4 Glucose Monitoring Global Market, by Products
4.1 Introduction
4.2 Invasive Glucose Monitoring
4.2.1 Self Glucose Monitoring
4.2.1.1 Blood Glucose Meter
4.2.1.2 Blood Glucose Testing Strips
4.2.1.3 Lancets
4.2.1.4 Others
4.2.2 Continuous Glucose Monitoring
4.2.2.1 Glucose Sensors
4.2.2.2 Transmitters and Receivers
4.3 Non-Invasive Glucose Monitoring
4.4 Lab Based Glucose Monitoring

5 Glucose Monitoring Global Market, by Sample Source
5.1 Introduction
5.2 Blood-Based Glucose Monitoring
5.3 Urine-Based Glucose Monitoring
5.4 Other Sources Based Glucose Monitoring

6 Glucose Monitoring Global Market, by End-Users
6.1 Introduction
6.2 Hospitals
6.3 Home Care
6.4 Private Clinics
6.5 Ambulatory Settings

7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest of North America
7.3 Europe
7.3.1 Germany
7.3.2 Italy
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia - Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Rest of Asia-Pacific
7.5 Rest of The World
7.5.1 Brazil
7.5.2 Middle East & Others
7.5.3 Rest of Latin America

8 Competitive Landscape
8.1 Introduction
8.2 New Product Launches
8.3 Collaboration & Partnerships
8.4 Other Developments

9 Major Companies
9.1 Abbott Laboratories, Inc
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 SWOT Analysis
9.2 Arkray, Inc.
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 SWOT Analysis
9.3 Ascensia Diabetes Care Holdings AG.
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 SWOT Analysis
9.4 B.Braun Melsungen AG
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 SWOT Analysis
9.5 Bio-Rad Laboratories
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 SWOT Analysis
9.6 Dexcom, Inc.
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 SWOT Analysis
9.7 LifeScan (Johnson & Johnson)
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 SWOT Analysis
9.8 Medtronic, Plc
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 SWOT Analysis
9.9 Sinocare Inc.
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 SWOT Analysis
9.10 Roche Holdings AG
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 SWOT Analysis

List of Tables

Table 1 Glucose Monitoring Global Market Revenue, by Region (2017-2025) ($Mn)
Table 2 Glucose Monitoring Devices Global Market Revenue, by Products, (2017-2025) ($Mn)
Table 3 Invasive Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 4 Invasive Glucose Monitoring Global Market Revenue, by Products, (2017-2025) ($Mn)
Table 5 Self-Monitoring Glucose Monitoring Global Market Revenue, by Products, (2017-2025) ($Mn)
Table 6 Self Monitoring Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 7 Blood Glucose Meter Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 8 Blood Glucose Testing Strips Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 9 Lancets Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 10 Others Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 11 Continuous Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 12 Continuous Glucose Monitoring Global Market Revenue, by Products, (2017-2025) ($Mn)
Table 13 Glucose Sensors Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 14 Transmitter and Receiver Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 15 Non-Invasive Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 16 Lab Based Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 17 Glucose Monitoring Global Market Revenue, by Sample Source, (2017-2025) ($Mn)
Table 18 Blood-Based Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 19 Urine-Based Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 20 Other Sources Based Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 21 Glucose Monitoring Global Market Revenue, by End User, (2017-2025) ($Mn)
Table 22 Hospital Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 23 Home Care Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 24 Private Clinics Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 25 Ambulatory Setting Glucose Monitoring Global Market Revenue, by Region, (2017-2025) ($Mn)
Table 26 Glucose Monitoring Global Market Revenue, by Region (2017-2025) ($Mn)
Table 27 North America Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 28 North America Invasive Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 29 North America Self Blood Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 30 North America Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 31 North America Glucose Monitoring Market Revenue, by Sample Source (2017-2025) ($Mn)
Table 32 North America Glucose Monitoring Market Revenue, by End-User (2017-2025) ($Mn)
Table 33 North America Glucose Monitoring Market Revenue, by Country (2017-2025) ($Mn)
Table 34 Europe Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 35 Europe Invasive Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 36 Europe Self Blood Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 37 Europe Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 38 Europe Glucose Monitoring Market Revenue, by Sample Source (2017-2025) ($Mn)
Table 39 Europe Glucose Monitoring Market Revenue, by End-User (2017-2025) ($Mn)
Table 40 Europe Glucose Monitoring Market Revenue, by Country (2017-2025) ($Mn)
Table 41 Asia-Pacific Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 42 Asia-Pacific Invasive Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 43 Asia-Pacific Self Blood Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 44 Asia-Pacific Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 45 Asia-Pacific Glucose Monitoring Market Revenue, by Sample Source (2017-2025) ($Mn)
Table 46 Asia-Pacific Glucose Monitoring Market Revenue, by End-User (2017-2025) ($Mn)
Table 47 Asia-Pacific Glucose Monitoring Market Revenue, by Country (2017-2025) ($Mn)
Table 48 Row Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 49 Row Invasive Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 50 Row Self Blood Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 51 Row Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Table 52 Row Glucose Monitoring Market Revenue, by Sample Source (2017-2025) ($Mn)
Table 53 Row Glucose Monitoring Market Revenue, by End-User (2017-2025) ($Mn)
Table 54 Row Glucose Monitoring Market Revenue, by Country (2017-2025) ($Mn)
Table 55 New Product Launches (2018-2019)
Table 56 Collaboration & Partnerships (2018-2019)
Table 57 Others (2018-2019)
Table 58 Abbott Laboratories, Inc: Total Revenue and R&D Expenses, (2016-2018) ($Mn)
Table 59 Abbott Laboratories, Inc: Total Revenue, by Segments, (2016-2018) ($Mn)
Table 60 Abbott Laboratories, Inc: Total Revenue, by Geography, (2016-2018) ($Mn)
Table 61 B Braun Melsungen: Total Revenue and R&D Expenses (2016-2018) ($Mn)
Table 62 B Braun Melsungen: Total Revenue, by Segments (2016-2018) ($Mn)
Table 63 B Braun Melsungen: Total Revenue, by Geography (2016-2018) ($Mn)
Table 64 Bio-Rad Laboratories: Total Revenue and R&D Expenses (2016-2018) ($Mn)
Table 65 Bio-Rad Laboratories: Total Revenue, by Segments, (2016-2018) ($Mn)
Table 66 Bio-Rad Laboratories: Total Revenue, by Geography, (2016-2018) ($Mn)
Table 67 Dexcom Inc: Total Revenue and R&D Expenses (2016-2018) ($Mn)
Table 68 Dexcom Inc: Total Revenue, by Geography (2016-2018) ($Mn)
Table 69 Johnson & Johnson: Total Revenue and R&D Expenses, (2016-2018) ($Mn)
Table 70 Johnson & Johnson: Total Revenue, by Segments, (2016-2018) ($Mn)
Table 71 Johnson & Johnson: Total Revenue, by Medical Devices Segments, (2016-2018) ($Mn)
Table 72 Johnson & Johnson: Total Revenue, by Geography, (2016-2018) ($Mn)
Table 73 Medtronic, Plc: Total Revenue and R&D Expenses, (2016-2018) ($Mn)
Table 74 Medtronic, Plc: Total Revenue, by Segments, (2016-2018) ($Mn)
Table 75 Medtronic, Plc: Total Revenue, by Geography, (2016-2018) ($Mn)
Table 76 Roche Holdings AG: Total Revenue and R&D Expenses, (2016-2018) ($Mn)
Table 77 Roche Holdings AG: Total Revenue, by Segments, (2016-2018) ($Mn)
Table 78 Roche Holdings AG: Diagnostics Revenue, by Types, (2016-2018) ($Mn)
Table 79 Roche Holdings AG: Total Revenue, by Geography, (2016-2018) ($Mn)

List of Figures

Figure 1 Glucose Monitoring Global Market Revenue, by Region (2017-2025) ($Mn)
Figure 2 Research Methodology: Glucose Monitoring Global Market
Figure 3 Glucose Monitoring Global Market: Top-Down and Bottom-Up Approach
Figure 4 Glucose Monitoring Global Market: Forecasting Model
Figure 5 Glucose Monitoring Global Market: Market Breakdown & Data Triangulation
Figure 6 Glucose Monitoring Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Glucose Monitoring Global Market: Patent Filing, by Major Players (2014-2019)
Figure 9 Glucose Monitoring Market: Porter’S Analysis
Figure 10 Glucose Monitoring Global Market: Supply Chain Analysis
Figure 11 Glucose Monitoring Global Market Share Analysis, by Key Players, 2018
Figure 12 Self Blood Glucose Monitoring Global Market Share Analysis, by Key Players, 2018
Figure 13 Continuous Glucose Monitoring Global Market Share Analysis, by Key Players, 2018
Figure 14 Glucose Monitoring Global Market Revenue, by Products (2018 V/S 2025) ($Mn)
Figure 15 Invasive Glucose Monitoring Global Market Share, by Products (2018 V/S 2025) (%)
Figure 16 Glucose Monitoring Global Market Revenue, by Products (2018 V/S 2025) ($Mn)
Figure 17 Self-Monitoring Glucose Monitoring Global Market Revenue, by Products (2018 V/S 2025) (%)
Figure 18 Self Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 19 Blood Glucose Meter Global Market Revenue, by Region (2018 V/S 2025) ($Mn)
Figure 20 Blood Glucose Testing Strips Global Market Share, by Region (2018 V/S 2025) (%)
Figure 21 Lancets Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 22 Others Global Market Revenue, by Region (2018 V/S 2025) ($Mn)
Figure 23 Continuous Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 24 Continuous Glucose Monitoring Global Market Revenue, by Products (2018 V/S 2025) ($ Mn)
Figure 25 Glucose Sensors Global Market Share, by Products (2018 V/S 2025) (%)
Figure 26 Transmitter and Receiver Global Market Share, by Region (2018 V/S 2025) (%)
Figure 27 Non-Invasive Glucose Monitors Global Market Share, by Region (2018 V/S 2025) (%)
Figure 28 Lab Based Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 29 Glucose Monitoring Global Market Share, by Sample Source (2018 V/S 2025) (%)
Figure 30 Blood-Based Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 31 Urine-Based Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 32 Other Sources Based Glucose Monitoring Global Market Revenue, by Region (2018 V/S 2025) ($Mn)
Figure 33 Glucose Monitoring Global Market Share, by End-User (2018 V/S 2025) (%)
Figure 34 Hospital Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 35 Home Care Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 36 Private Clinics Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 37 Ambulatory Settings Glucose Monitoring Global Market Share, by Region (2018 V/S 2025) (%)
Figure 38 Glucose Monitoring Global Market Revenue, by Region (2017 - 2025) ($Mn)
Figure 39 North America Glucose Monitoring Market Revenue, by Products (2018) ($Mn)
Figure 40 North America Self Blood Glucose Monitoring Market Share, by Products (2018 V/S 2025) (%)
Figure 41 North America Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Figure 42 North America Glucose Monitoring Market Share, by Sample Source (2018 V/S 2025) (%)
Figure 43 North America Glucose Monitoring Market Share, by End-User (2018) (%)
Figure 44 North America Glucose Monitoring Market Revenue, by Country (2018-2025) ($Mn)
Figure 45 U.S. Glucose Monitoring Market Revenue, by Products, (2018 Vs 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 46 U.S. Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 47 Rest of North America Glucose Monitoring Market Revenue, by Product, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 48 Rest of North America Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 49 Europe Glucose Monitoring Market Revenue, by Products (2018) ($Mn)
Figure 50 Europe Self Blood Glucose Monitoring Market Share, by Products (2018 V/S 2025) (%)
Figure 51 Europe Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Figure 52 Europe Glucose Monitoring Market Share, by Sample Source (2018 V/S 2025) (%)
Figure 53 Europe Glucose Monitoring Market Share, by End-User (2018) (%)
Figure 54 Europe Glucose Monitoring Market Revenue, by Country (2018 V/S 2025) ($Mn)
Figure 55 Germany Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 56 Germany Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 57 Italy Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 58 Italy Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 59 France Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 60 France Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 61 Rest of Europe Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 62 Rest of Europe Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 63 Asia-Pacific Glucose Monitoring Market Revenue, by Products (2018) ($Mn)
Figure 64 Asia-Pacific Self Blood Glucose Monitoring Market Revenue, by Products (2018 V/S 2025) ($Mn)
Figure 65 Asia-Pacific Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Figure 66 Asia-Pacific Glucose Monitoring Market Revenue, by Sample Source (2018 V/S 2025) ($Mn)
Figure 67 Asia-Pacific Glucose Monitoring Market Share, by End-User (2018) (%)
Figure 68 Asia-Pacific Glucose Monitoring Market Revenue, by Country (2018 V/S 2025) ($Mn)
Figure 69 Japan Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 70 Japan Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 71 China Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 72 China Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 73 India Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 74 India Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 75 Rest of Asia-Pacific Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 76 Rest of Asia-Pacific Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 77 Row Glucose Monitoring Market Revenue, by Products (2018) ($Mn)
Figure 78 Row Self Blood Glucose Monitoring Market Share, by Products (2018 V/S 2025) (%)
Figure 79 Row Continuous Glucose Monitoring Market Revenue, by Products (2017-2025) ($Mn)
Figure 80 Row Glucose Monitoring Market Revenue, by Sample Source (2018 V/S 2025) ($Mn)
Figure 81 Row Glucose Monitoring Market Share, by End-User (2018) (%)
Figure 82 Row Glucose Monitoring Market Revenue, by Country (2018 V/S 2025) ($Mn)
Figure 83 Brazil Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 84 Brazil Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 85 Middle East & Others Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 86 Middle East & Others Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 87 Rest of Latin America Glucose Monitoring Market Revenue, by Products, (2018 V/S 2025) ($Mn), by Sample Source (2018 V/S 2025) ($Mn)
Figure 88 Rest of Latin America Glucose Monitoring Market Revenue, by End-User (2018) ($Mn)
Figure 89 Key Growth Strategies (2018–2019)
Figure 90 SWOT: Abbott Laboratories
Figure 91 SWOT: Arkray, Inc
Figure 92 SWOT: Ascensia Diabetes Care
Figure 93 SWOT: B Braun Melsungen
Figure 94 SWOT: Bio-Rad Laboratories
Figure 95 SWOT: Dexcom Inc.
Figure 96 SWOT: LifeScan (Johnson & Johnson)
Figure 97 SWOT: Medtronic, Plc
Figure 98 SWOT: Sinocare
Figure 99 SWOT: Roche Holdings AG

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • A&T CORPORATION
  • ABBOTT LABORATORIES
  • ACON DIABETES CARE INTERNATIONAL
  • ADALTIS
  • AGAMATRIX INC
  • ALLIANCE INTERNATIONAL
  • ALLMEDICUS
  • AMBROSIA SYSTEMS
  • ANDON HEALTH CO LTD
  • APEX BIOTECHNOLOGY CORP
  • ARKRAY
  • ASCENSIA DIABETES CARE
  • B.BRAUN
  • BECTON DICKINSON
  • BEIJING YICHENG BIOELECTRONICS TECHNOLOGY CO., LTD.
  • BEURER GMBH
  • BIO-RAD LABORATORIES
  • BIOCHEMICAL SYSTEMS INTERNATIONAL
  • BIOLAND TECHNOLOGY
  • BIONIME CORPORATION
  • BIOPTIK TECHNOLOGY
  • BIOTELEMETRY INC
  • BIOTEST MEDICAL CORPORATION
  • BODYTEL GMBH
  • BREMED LIMITED
  • CAMBRIDGE SENSORS
  • CAREMATIX INC
  • CERAGEM MEDISYS INC.
  • CHUNGDO PHARM. CO., LTD
  • CONTEC MEDICAL SYSTEMS
  • CONVERGENT TECHNOLOGIES
  • DANAHER
  • DARIO
  • DELBIO INCORPORATION
  • DEXCOM, INC
  • DIABETOMICS, INC
  • DIAMONTECH
  • ECHO THERAPEUTICS
  • EKF DIAGNOSTICS
  • EMSIG GMBH CO
  • ENTRA HEALTH SYSTEMS LLC
  • EPS BIOTECHNOLOGY CORP.
  • ERBA DIAGNOSTICS
  • ESER DIGITAL
  • EVIA MEDICAL TECHNOLOGIES
  • FIA BIOMED GMBH
  • FORA CARE, INC
  • GE
  • GENERAL LIFE BIOTECHNOLOGY
  • GENESIS HEALTH TECHNOLOGIES
  • GLOOKO
  • GLUCO RX
  • GLUCOSTRATUS LTD
  • GLYSENS INCORPORATED
  • GLYSURE LIMITED
  • HANGZHOU SEJOY ELECTRONICS & INSTRUMENTS
  • HEMOCUE AB
  • HMD BIOMEDICAL
  • HUBDIC CO LTD
  • HYGEIA, INC.
  • I-SENS
  • IDEAL LIFE INC.
  • IHEALTH LABS INC
  • IME-DC GMBH
  • IN4 TECHNOLOGY CORP
  • INFOPIA CO LTD
  • INSIDE BIOMETRICS
  • INSULET CORPORATION
  • INTEGRITY APPLICATIONS
  • INTERNATIONAL BIOMEDICAL
  • INTUITY MEDICAL, INC
  • IXENSOR COMPANY LTD.
  • JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD
  • K-JUMP HEALTH CO., LTD
  • L-TAC MEDICARE
  • LIFE PLUS
  • LIFOTRONIC
  • LIGHT TOUCH MEDICAL INC
  • LOBECK MEDICAL AG
  • MEDISANA
  • MEDIWISE
  • MEDTRONIC PLC
  • MENARINI GROUP
  • MICO NANOBIOSYS LTD
  • NATIONAL DIAGNOSTIC PRODUCTS
  • NEMAURA MEDICAL INC
  • NIPRO
  • NOVA BIOMEDICAL
  • NOVIOSENSE
  • OK BIOTECH CO. LTD
  • OMRON HEALTHCARE
  • OSANG HEALTH CARE CO LTD
  • PALMDOC
  • PENDIQ
  • PEPEX BIOMEDICAL
  • PHARMA TECH SOLUTIONS INC
  • PHILOSYS INC
  • PLATINUM EQUITY (LIFE SCAN INC)
  • PREDIKTOR MEDICAL
  • PRODIGY DIABETES CARE, LLC
  • ROCHE DIAGNOSTICS
  • ROMED HOLLAND
  • SANOFI
  • SD BIOSENSOR
  • SENSEONICS
  • SINOCARE
  • SORRENTO BIOCHEMICAL, INC.
  • STAIRWAY LABORATORIES INC
  • SYN-KIT, INC.
  • TAIDOC TECHNOLOGY CORPORATION
  • TANDOM DIABETES CARE
  • TERUMO
  • THERMO FISHER SCIENTIFIC
  • TIANJIN EMPECS MEDICAL DEVICE CO., LTD.
  • TOSOH CORPORATION
  • TRINITY BIOTECH
  • TRULY INSTRUMENT LIMITED
  • TYSON BIORESEARCH INC
  • VISGENEER INC
  • VIVACHEK LABORATORIES, INC.
Note: Product cover images may vary from those shown
Adroll
adroll